Of these, 3 articles met the inclusion criteria
Novel long-acting GLP-2 analogue, FE 203799 (apraglutide), enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum
Follicles that responded are now producing mature, healthy hairs
Bottom Line While insurance coverage for GLP-1 weight-loss medications remains inconsistent, employees are not without options
Factors like weight, tolerance, and existing medical conditions impact the dose
Verify licensure and clinical oversight, understand that quality varies by pharmacy, and treat the combination as one prescriber-directed option among many